Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |